New Drug May Provide Option for Severe Cases of Eczema if Approved by FDA
What health issue did this study examine? Researchers are studying a potential new treatment option for moderate-to-severe eczema. The drug is called dupilumab. It belongs to a class of drugs known as biologics. Dupilumab is thought to work by blocking
